Form 4: Bone Biologics Corp Director Acquires Stock Options
SEC Form 4 Filing
Director Siddhesh Rajendra Angle reports acquisition of stock options in Bone Biologics Corp.
Summary
- Siddhesh Rajendra Angle, a director of Bone Biologics Corp, filed a Form 4 with the SEC.
- The filing reports the acquisition of non-employee stock options.
- The options were acquired on September 17, 2024.
- Angle directly owns 30,713 derivative securities following the reported transaction.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock option grants. The director's acquisition could be interpreted as a positive signal, but it's not definitively bullish.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into insider transactions, allowing investors to track the actions of company directors and officers.
Stakeholder Impact
- Shareholders may view the director's stock option acquisition as a sign of confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 08/23/2027 | Expiration date for Non-Employee Stock Option with exercise price of $387.26 |
| 10/26/2031 | Expiration date for Non-Employee Stock Option with exercise price of $1,260 |
| 10/15/2031 | Expiration date for Non-Employee Stock Option with exercise price of $1,260 |
| 01/01/2032 | Expiration date for Non-Employee Stock Option with exercise price of $844.8 |
| 09/13/2033 | Expiration date for Non-Employee Stock Option with exercise price of $5.12 |
| 09/17/2024 | Date of the reported transaction and grant date of new stock options. |
| 09/17/2034 | Expiration date for Non-Employee Stock Option with exercise price of $1.73 |
| 09/19/2024 | Date of signature on the Form 4 filing. |
Keywords
Form 4, stock options, Bone Biologics Corp, director, acquisition, BBLG, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.